Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Myofibroma × telapristone acetate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 16 Myofibroma 1 Fibroma 1 Anemia 1

Interventions

relugolix 2 telapristone acetate 1 estradiol, norethindrone drug combination 1 Uterine Artery Embolization 1 Tablets 1 Leuprolide 1 LFA102 monoclonal antibody 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01069094 2014-06-30

A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata

Repros Therapeutics Inc.

Phase 1/2 Completed

Leiomyoma, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡